Want to join the conversation?
Celgene International Sarl, a subsidiary of $CELG, said it will present phase 1b study data evaluating effects of investigational oral GED-0301 (mongersen) on both endoscopic response and clinical remission in patients with active Crohn's disease. Crohn's disease is an immune-mediated, chronic inflammatory condition of the gastrointestinal tract.
$NFLX a monster move, going up. Expect making some money on Monday.
$AMD down more than 6% even after posting above consensus third quarter results.
$MCD stock rose more than 2% after it posted better than expected 3Q16 results, driven by global same-store sales growth. Meanwhile, earnings and revenue were lower than last year, hurt by refranchising efforts.